India Approves First Dengue Vaccine for Individuals Aged 4 to 60 Years
The Central Drugs Standard Control Organisation, under the Ministry of Health and Family Welfare, has granted marketing authorisation to Qdenga, a live attenuated tetravalent dengue vaccine manufactured by Takeda GmbH in Germany. The vaccine will be imported and distributed in India by Takeda Biopharmaceuticals India Private Limited.